Dr. Kini is internationally acclaimed for her special expertise in performing complex and high risk interventional cases especially in chronic total occlusion, calcific and bifurcation lesions. She has extensive experience with the techniques of mitral, aortic balloon valvuloplasty and septal (alcohol) ablation for the treatment of obstructive hypertrophic cardiomyopathy. She has been among the first interventional cardiologists in the country to use transcutaneous aortic valve implantation procedure in the treatment of patients with aortic stenosis and performs MitralClip procedures for patients with mitral regurgitation.

Dr. Kini performs over 1,000 coronary interventions annually, the highest number by a female interventionist in the United States, with an extremely low complication rate of less than 0.3 percent; an official report from The Department of Health recognized Dr. Kini as the safest operator among 350 other physicians in the state of New York numerous times (2004-2006; 2005-2007; 2009-2011; 2010-2012; 2011-2013; 2012-2014; 2013-2015; 2014-2016).

She is the recipient of 2011 Dean’s Award for Excellence in Clinical Medicine at The Mount Sinai Medical Center. She also received the Physician of the year award in 2014 by the Mount Sinai Hospital nurses. She received the Excellence in Medicine Award by the National Association of Physicians of India (AAPI) in July 2016. She received the prestigious, Ellis Island Medal of Honor in May 2017, which is the highest award given to any immigrant civilian. She is the recipient of AHA “The Heart of Gold Award”, June 2018 and Jacobi Medallion Award 2019 for Breakthroughs in Clinical Care.

Dr. Kini is a keen researcher, particularly recognized for her studies pertaining to intra-coronary imaging studies including IVUS, NIRS and OCT, and trials such as YELLOW and ORBID have made major headlines. She has published more than 100 peer reviewed scientific publications, and book chapters in major cardiology textbooks. Dr. Kini has been the principal or co-investigator in numerous randomized clinical trials. She has been on the editorial boards and reviews for prestigious journals in the field of cardiovascular interventions. The most recent YELLOW II study was an ambitious translational combination of multi-modality imaging with clinically relevant cellular biology and comprehensive transcriptomics. She is a member of the Royal College of Physician of London and Fellow of the American College of Cardiology.

She has been most recently leading the development of iPhone/Android Apps to help in many areas of complex interventional cardiology procedures: (1) the BifurcAID on treatment coronary bifurcation lesions utilizing systematic decision-making algorithms (2) the OCTAID on how to perform and interpret optical cohesion tomography imaging during coronary interventions (3) the TranseptAID on how to safely transverse the interatrial septum (4) the TAVRCathAID on how to efficiently perform coronary angiography through the struts of TAVR valve frames and (5) CalcificAID, an educational tool for treatment of calcific lesions. These Apps are developed in collaboration with her fellows and the Mount Sinai App-lab and available for free download the iTunes or Google Play Stores. They already have more than 22,000 downloads worldwide. Since the Apps are spreading exponentially, they exemplify her ability to modify teaching methods to adapt them to contemporary trends of her trainees.

Dr. Kini is an excellent teacher, and is dedicated to the teaching of both cardiology and interventional fellows. Due to her passion in teaching, the graduating interventional fellows Batch of 2013 who were trained under her mentorship in the Interventional Cardiology Fellowship Program created a teaching award in her name “The Annapoorna S. Kini Fellows Choice Award” for excellence in teaching. She has received this award every year since its inception.

Her achievements are not only limited to serving as the Director of the Annual Live Symposium of Complex Coronary & Vascular Cases at The Mount Sinai Medical Center, one of the most attended and respected meetings in the field of interventional cardiology in the country, but as also being the Director of monthly web conferences on Live Complex Coronary Intervention Cases. Dr. Kini plays a key role in educating interventionalists globally in the technical aspects of complex coronary interventions and structural heart procedures via monthly webcasts on www.ccclivecases.org with a worldwide audience of several thousand physicians in over 137 countries.

Pass by Dr. Kini’s lab any day of the week, any hour of the day, and you will hear the unison applause that erupts from the whole team when a difficult complex intervention is completed. Moreover to protocols, which have been disseminated to many centers in USA to guide other centers, getting the result similar to ours. The ultimate mission of these endeavors is to provide best care to the interventional cardiac patients and to strive to make Mount Sinai Cardiology #1 in the United States.

Dr. Samin K. Sharma is a world renowned interventional cardiologist and serves as Director of Clinical and Interventional Cardiology at The Mount Sinai Hospital. Dr. Sharma is well known for performing the maximum number of complex coronary interventions in the United States. He has had the highest success rates with the lowest complication rates in New York State for nearly two decades. Under the leadership of Dr. Sharma, The Mount Sinai Hospital Catheterization Laboratory has become a center of excellence.

In addition to coronary interventions, Dr. Sharma also specializes in the non-surgical treatment of aortic and mitral stenosis. Dr. Sharma is a leader within the field and he previously served on the New York State Cardiac Advisory Board. He has numerous publications and has authored multiple book chapters. Dr. Sharma has received multiple distinctions including the American Heart Association Achievement in Cardiovascular Science and Medicine Award. Dr. Sharma has been awarded multiple awards for his teaching of fellows within the United States and internationally. Under the directorship of Dr. Sharma, the Complex Coronary, Valvular and Vascular Cases CCVVC Live Symposium has had an overwhelming attendance each year and his initiation of the monthly live case web series reached its 100th case in 2017.

Dr. Yuliya Vengrenyuk is an Assistant Professor of Medicine at the Icahn School of Medicine and the Director of the Intravascular Imaging Core Laboratory at The Mount Sinai Hospital in New York. Dr. Vengrenyuk has numerous papers related to the use of OCT, IVUS and NIRS in percutaneous coronary intervention and the assessment of the effects of statin therapy on plaque morphology. In 2017, she co-authored the “Atlas of Coronary Intravascular Optical Coherence Tomography”.

Andrew Vengrenyuk is an Associate Research Coordinator at the Icahn School of Medicine at Mount Sinai